The status of CHD1L expression in breast cancer and its clinical and prognostic significances is uncertain, but as described above, amplification of 1q has already been frequently detected in primary breast cancer, suggesting that one or more oncogenes within the amplicon may correlated with the development of this breast cancer. The gene discussed is CHD1L; the disease is breast carcinoma.